Some cancer patients in Windsor-Essex who received diluted chemotherapy remain unsatisfied with the settlement of a class-action lawsuit.
Louise Martens says a small group of the patients plan to meet on Monday to discuss their next steps.
Martens is also demanding a public apology since the quantity of chemo given to patients in 2012 and 2013 was estimated to be seven to 10 per cent less than prescribed.
The $2.375 million class action lawsuit received court approval last Friday.
Some of the nearly 1,200 patients were disappointed to discover their share worked out to about $1,500 each, following legal costs and payments to Ontario and New Brunswick health insurers.
